HEM Pharma financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

HEM파마KRX:376270 · KOSDAQ

₩34,800+5.61%

2026-10-02 close

HEM Pharma's 2025 annual results accompany close-price data dated 2026-10-02. 2025 revenue was KRW 12.98B. 2025 operating profit was −KRW 15.58B.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy